4-[(1-{[2-(2,6-difluorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-3-yl)methyl]morpholine
Structure Info
- Chemspace ID
- CSSS00027664564 (In-Stock Screening Compounds)
- CAS
- 2093835-50-6
- IUPAC Name
- 4-[(1-{[2-(2,6-difluorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-3-yl)methyl]morpholine
- Mol formula
- C20H25F2N3O2
- Mol weight
- 377 Da
- Catalog Number(s)
- CSC027664564, Z1498474319, s_2230____20626890____7689388
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.56
- Heavy atoms count
- 27
- Rotatable bond count
- 5
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.55
- Polar surface area (Å)
- 42
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
![Chemical structure of 4-[(1-{[2-(2,6-difluorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-3-yl)methyl]morpholine (C20H25F2N3O2) - CSSS00027664564](/st/structure/200/7ccbf4bea88941628bfa4dc092e93fb7/FC1%253DCC%253DCC%2528F%2529%253DC1C1%253DNC%2528CN2CCCC%2528CN3CCOCC3%2529C2%2529%253DCO1.png "C20H25F2N3O2")
- Zoom the structure
- CSSS00027664564
Items Overall 4 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 1 mg | 83.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 2 mg | 85.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 5 mg | 91.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 10 mg | 102.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 4-[(1-{[2-(2,6-difluorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-4-yl)methyl]morpholine - CSSS00027665308](/st/structure/200/2e81e6e8ff58f25ed49b3b9cec3af3f0/FC1%253DCC%253DCC%2528F%2529%253DC1C1%253DNC%2528CN2CCC%2528CN3CCOCC3%2529CC2%2529%253DCO1.png)
![Chemical structure of 4-[(1-{[2-(3,4-difluorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-3-yl)methyl]morpholine - CSSS00027424939](/st/structure/200/4918067b9ed46365dd79827c3d590b47/FC1%253DCC%253DC%2528C%253DC1F%2529C1%253DNC%2528CN2CCCC%2528CN3CCOCC3%2529C2%2529%253DCO1.png)
![Chemical structure of 4-[(1-{[2-(4-fluorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-3-yl)methyl]morpholine - CSSS00027424865](/st/structure/200/e8fabf19fea5ea05a08cb89549d12088/FC1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%2528CN2CCCC%2528CN3CCOCC3%2529C2%2529%253DCO1.png)
![Chemical structure of 4-[(1-{[2-(3,4-difluorophenyl)-1,3-oxazol-4-yl]methyl}pyrrolidin-3-yl)methyl]morpholine - CSSS00027573265](/st/structure/200/04667ca684901eb0d318fc470cece9dd/FC1%253DCC%253DC%2528C%253DC1F%2529C1%253DNC%2528CN2CCC%2528CN3CCOCC3%2529C2%2529%253DCO1.png)
![Chemical structure of 4-[(1-{[2-(3-chlorophenyl)-1,3-oxazol-4-yl]methyl}piperidin-3-yl)methyl]morpholine - CSSS00027424856](/st/structure/200/71ad8885c8b63362f99c825c312488c6/ClC1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%2528CN2CCCC%2528CN3CCOCC3%2529C2%2529%253DCO1.png)
![Chemical structure of 4-[(1-{[2-(3-fluorophenyl)-1,3-oxazol-4-yl]methyl}pyrrolidin-3-yl)methyl]morpholine - CSSS00027574413](/st/structure/200/f3b427b735c801e512dce59be248a907/FC1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%2528CN2CCC%2528CN3CCOCC3%2529C2%2529%253DCO1.png)
![Chemical structure of 4-{[(3R)-1-({2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl}methyl)piperidin-3-yl]methyl}morpholine - CSSS00589557496](/st/structure/200/32c891daab261c5e09a5df89ab8209ce/FC%2528F%2529%2528F%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%2528CN2CCC%255BC%2540%2540H%255D%2528CN3CCOCC3%2529C2%2529%253DCO1.png)
